Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Child Neurology

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/08830738060210011601PMID 16551453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.

  2009cited by this paper
• Elevation of high-density lipoprotein in epileptic patients treated with phenytoin.

  2009cited by this paper
• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• Lipoprotein(a) Concentration Increases during Treatment with Carbamazepine

  2003cited by this paper
• Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood

  2001cited by this paper
• Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients

  2000cited by this paper
• The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.

  2000cited by this paper
• Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children.

  2000cited by this paper
• Increased High‐Density Lipoprotein Cholesterol in Patients with Epilepsy Treated with Carbamazepine: A Gender‐Related Study

  1999cited by this paper
• Quantitative determination of cholesterol in lipoprotein fractions by electrophoresis.

  1999cited by this paper
• Serum lipids and lipoproteins in patients treated with antiepileptic drugs.

  1998cited by this paper
• Cholesterol in Childhood

  1998cited by this paper
• Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants

  1997cited by this paper
• Serum lipids in epileptic children treated with carbamazepine and valproate

  1997cited by this paper
• The effects of long‐term anticonvulsive treatment on serum lipid profile

  1997cited by this paper
• [The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population].

  1996cited by this paper
• Effects of long‐term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy

  1995cited by this paper
• Distribution of Serum Lipoprotein (a) Concentrations in a Healthy Turkish Population

  1994cited by this paper
• Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.

  1993cited by this paper
• Changes of serum lipid patterns during long-term anticonvulsive treatment

  1993cited by this paper
• Serum lipid levels during carbamazepine medication. A prospective study.

  1993cited by this paper
• Total Cholesterol, High‐Density Lipoprotein Cholesterol, and Triglycerides in Children Receiving Antiepileptic Drugs

  1992cited by this paper
• National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

  1992cited by this paper
• Carbamazepine‐Induced Increases in Total Serum Cholesterol: Clinical and Theoretical Implications

  1992cited by this paper
• Early expression of the apolipoprotein (a) gene: relationships between infants' and their parents' serum apolipoprotein (a) levels.

  1992cited by this paper
• Lipoprotein(a) profiles and evolution in newborns.

  1991cited by this paper
• Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital

  1991cited by this paper
• Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis.

  1989cited by this paper
• Cardiovascular risk factors in children and early prevention of heart disease.

  1988cited by this paper
• Microsomal enzyme induction, lipoproteins and atherosclerosis.

  1988cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

  1986cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study

  1986cited by this paper
• Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy.

  1985cited by this paper
• Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.

  1985cited by this paper
• Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid.

  1985cited by this paper
• Effect of Anticonvulsant Drugs on Plasma Total Cholesterol, High-Density Lipoprotein Cholesterol, and Apolipoproteins A and B in Children with Epilepsy

  1985cited by this paper
• A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.

  1984cited by this paper
• Heart Disease Mortality and Morbidity in Patients with Epilepsy

  1984cited by this paper
• Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.

  1983cited by this paper
• Increase of low serum concentrations of high‐density lipoprotein (HDL) cholesterol in TIA‐patients treated with phenytoin.

  1983cited by this paper
• The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children

  1983cited by this paper
• Induction and lipoproteins.

  1982cited by this paper
• Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin

  1982cited by this paper
• Relationship Between Plasma High‐Density Lipoprotein Cholesterol and Anticonvulsant Levels in Epileptics

  1982cited by this paper
• Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants.

  1980cited by this paper
• Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density-lipoprotein cholesterol in normal subjects.

  1979cited by this paper
• Increase in serum cholesterol during phenytoin treatment.

  1975cited by this paper

• Epilepsili Çocuklarda Antiepileptik Tedavinin Metabolik ve İnflamatuvar Etkileri

  2026cites this paper
• Editorial: The role of nutrition in pediatric chronic diseases: a focus on metabolic, genetic, and palliative care challenges

  2026cites this paper
• Role of different anti-seizure medications on carotid intima–media thickness: A systematic review and meta-analysis

  2025cites this paper
• Serum HDL-C levels in children with epilepsy: a single-center retrospective study

  2025cites this paper
• Temporal trends, in-hospital outcomes, and risk factors of acute myocardial infarction among patients with epilepsy in the United States: a retrospective national database analysis from 2008 to 2017

  2024cites this paper
• Increased vascular risk factors, atherosclerosis, and psychological distress among Indian adults with refractory epilepsy in comparison to well-controlled epilepsy.

  2023cites this paper
• Effect of long-term valproic acid therapy on lipid profiles in paediatric patients with epilepsy: a meta-analysis

  2022cites this paper
• Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review

  2020cites this paper
• Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.

  2019cites this paper
• A Hospital Based Comparative Study on Effect of Lipid Profile in Patients Treated with Older and Newer Anti Epileptic Drugs

  2018cites this paper
• Sodium Valproate as a Probable Cause of Gut Gangrene: Report of Two Unusual Cases

  2018cites this paper
• COMPARATIVE EVALUATION OF SOME ANTIEPILEPTIC DRUGS ON LIPID PROFILE AND CAROTID INTIMA THICKNESS IN A SAMPLE OF EGYPTIAN CHILDREN: A ONE YEAR PROSPECTIVE STUDY.

  2016cites this paper
• Favorable change of lipid profile after carbamazepine withdrawal

  2016cites this paper
• Drug-Induced Dyslipidemia

  2015cites this paper
• Effect of Carbamazepine and Valproate Monotherapy on Cardiovascular Risks in Epileptic Children.

  2015cites this paper
• Comorbidity of childhood epilepsy.

  2015cites this paper
• The effects of antiepileptic drugs on vascular risk factors: a narrative review.

  2014cites this paper
• Effects of Longterm Antiepileptic Drugs on Vascular Risk Factors and Atherosclerosis.

  2013cites this paper
• A Practitioner’s Guide to Prescribing Phenobarbital for Adults with Intellectual Disabilities

  2012cites this paper
• Anticonvulsants Used in Child and Adolescent Psychiatric Disorders

  2012cites this paper
• Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B12, folate levels, and lipid profiles in epileptic children treated with valproic acid

  2011cites this paper
• Antiepileptic Drugs and Markers of Vascular Risk

  2010cites this paper
• Management Challenges in Children With Both Epilepsy and Intellectual Disability

  2010cites this paper
• Correspondence on ``Lipid Profile, Apolipoproteins A and B in Children With Epilepsy''

  2009cites this paper
• Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein

  2009cites this paper
• VALPORIC ACID: IS IT SAFE TO USE IN EPILEPTIC PEDIATRIC PATIENT?

  2009cites this paper
• Body Mass Index and Serum Lipid Changes During Treatment with Valproic Acid in Children with Epilepsy

  2009cites this paper
• Atherosclerotic risk among children taking antiepileptic drugs

  2009influential citation
• Metabolic effects of AEDs: impact on body weight, lipids and glucose metabolism.

  2008cites this paper
• Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy

  2008cites this paper
• Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.

  2008cites this paper
• The adverse effects of antiepileptic drugs in children

  2007cites this paper
• Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship?

  2007cites this paper
• Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.

  2006cites this paper